US · Healthcare

Neurizon Therapeutics Limited (NUZTF)

Biotechnology

Neurizon Therapeutics Limited (NUZTF) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for NUZTF

P/E ratio

18.00

Neurizon Therapeutics Limited (NUZTF) — FAQ

What is NUZTF's P/E ratio?

The price-to-earnings (P/E) ratio for Neurizon Therapeutics Limited (NUZTF) is 18.00 (data as of 2026-03-24).

Does Neurizon Therapeutics Limited pay a dividend?

Dividend yield is not available in the current snapshot for Neurizon Therapeutics Limited (NUZTF). Check the MyAverix Finance app for the latest dividend data.

What sector is Neurizon Therapeutics Limited in?

Neurizon Therapeutics Limited (NUZTF) is classified in the Healthcare sector (Biotechnology industry).

What exchange is NUZTF listed on?

NUZTF is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)